DoubleTree Suites by Hilton Hotel
515 Fellowship Road
Mount Laurel, NJ 08054
Phone: 856.778.8999
Tuesday, April 17, 2018
or
The Carriage House
25 South Pitney Road
Galloway, NJ 08205
Phone: 609.748.2400
Tuesday, May 1, 2018
Registration is required prior to the conference. Space is limited, so registrations will be accepted on a first-come, first-served basis. No walk-in registrations will be accepted.
Registration Fee: Free (Preregistration is required.)
Credits: 2.5 AMA PRA Category 1 Credits™
2.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.
Agenda:
5:45 p.m. – 6:10 p.m.: Registration/Buffet Dinner
6:10 p.m. – 6:20 p.m.: Welcome/Pre-Evaluation
6:20 p.m. – 6:40 p.m.: Keynote: Precision Medicine and Evolving Indications for Hereditary Cancer Genetics
Robert A. Somer, MD
6:40 p.m. – 7:10 p.m.: Overview of Cancer Genetics
Vanessa Manso, MS, LCGC, or Matthew Share, MS, LCGC
7:10 p.m. – 7:20 p.m.: Break
7:20 p.m. – 7:50 p.m.: Focus on Genetics and Gastrointestinal Cancers
Jamin C. Morrison, MD
7:50 p.m. – 8:20 p.m.: Focus on Genetics and Breast Cancer
Ahmed Kamel Abou Hussein, MD, or Preeti Sudheendra, MD
8:20 p.m. – 8:50 p.m.: Question and Answer Period/Post-Evaluation
The intended audience for this conference includes primary care physicians, obstetricians, gynecologists, gastroenterologists, medical oncologists, surgical oncologists, and radiation oncologists. Physician assistants, residents, fellows, advanced practice nurses, genetics professionals, tumor registrars, and other allied health professionals with an educational need or interest in this topic may also attend.
Overall Learner Objectives:
- Describe current approaches to genetic testing for hereditary cancer syndromes.
- Identify potential benefits and limitations of the multigene panel testing approach for hereditary cancer syndromes.
- Discuss the implications, risks, and benefits of genetic testing for the individual and their family.
Click here to view and print the CME brochure on The Role of Cancer Genetics in Precision Medicine.